Rio de Janeiro – June 8, 2016. SOLACI-SBHCI 2016, the largest meeting on Interventional Cardiology in Latin America started with more than 1500 attendees. After the opening, by Congress President Marcelo Josén de Carvalho Cantarelli, we honored Dr. José Eduardo Sousa, the first to perform a coronary catheterization in Brazil, 50 years ago. After<a href="https://solaci.org/en/2016/06/15/june-8-2016/" title="Read more" >...</a>
Do you need an update on Structural Cardiomyopathy? If so, clear your schedule from July 27 thru 29. We are hosting the 7th Latin American Symposium on Structural Cardiomyopathy, to be held at the Intercontinental Hotel in Cali, Colombia, organized by Angiografía de Occidente S.A. Featuring lectures of national and international relevance and the presence<a href="https://solaci.org/en/2016/05/27/vii-latin-american-symposium-on-structural-cardiomyopathy/" title="Read more" >...</a>
Original title: Incidence and clinical impact of infective endocarditis after transcatheter aortic valve implantation. Reference: Manuel Martínez-Sellés et al. EuroIntervention 2015;10-online publish-ahead-of-print February 2015. Prosthesis endocarditis is a complication with serious clinical consequences due to its high morbimortality. Infective endocarditis (IE) in TAVI has been described in few cases and, in cohort studies, it occurs within 0 to<a href="https://solaci.org/en/2015/03/13/incidence-and-clinical-impact-of-post-tavi-infective-endocarditis/" title="Read more" >...</a>
Original title: Impact of chronic kidney disease on the outcome of transcatheter aortic valve implantation: results from the FRANCE 2 Registry. Reference: Atsushi Oguri, et al. EuroIntervention 2015;10:e1-9 Globally, 13% of patients present kidney failure, which has been associated to a worse evolution not only of TAVI outcomes but also of other cardiovascular intervention outcomes. Most studies, including<a href="https://solaci.org/en/2015/02/19/impact-of-kidney-function-on-tavi-outcome/" title="Read more" >...</a>
Original title: Impact of Post-Procedural Aortic Regurgitation on Mortality Alter Trancatheter Aortic Valve Implantation Reference: Kentaro Hayashida, et al. J Am Coll Interv 2012;5:1247-56 Transcatheter aortic valve implantation (TAVI) sprung up as a valid strategy to treat patients with severe high risk AS (aortic stenosis). However, residual aortic regurgitation (post AR) and post-dilation remain unsolved. Between October 2006<a href="https://solaci.org/en/2013/01/15/aortic-insufficiency-has-a-poor-prognosis-in-tavi/" title="Read more" >...</a>